Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lanni

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Medicinal Chemistry|November 24, 1995
(R)-(+)-N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl- 2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitorC D Brooks, A O Stewart, A Basha, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitorsR L Bell, J B Bouska, P E Malo, et al.
Molecular Psychiatry|August 9, 2007
Conformationally altered p53: a novel Alzheimer's disease marker?C Lanni, M Racchi, G Mazzini, et al.
Journal of Medicinal Chemistry|September 27, 1996
5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-onesP A Bhatia, C D Brooks, A Basha, et al.
Annals of Internal Medicine|December 1, 1993
The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthmaE Israel, P Rubin, J P Kemp, et al.
Journal of Medicinal Chemistry|June 20, 1997
Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitorsA O Stewart, P A Bhatia, J G Martin, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Medicinal Chemistry|November 24, 1995
(R)-(+)-N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl- 2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitorC D Brooks, A O Stewart, A Basha, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitorsR L Bell, J B Bouska, P E Malo, et al.
Molecular Psychiatry|August 9, 2007
Conformationally altered p53: a novel Alzheimer's disease marker?C Lanni, M Racchi, G Mazzini, et al.
Journal of Medicinal Chemistry|September 27, 1996
5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-onesP A Bhatia, C D Brooks, A Basha, et al.
Annals of Internal Medicine|December 1, 1993
The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthmaE Israel, P Rubin, J P Kemp, et al.
Journal of Medicinal Chemistry|June 20, 1997
Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitorsA O Stewart, P A Bhatia, J G Martin, et al.
Pageof 4